Renaissance Technologies - IMMUNOVANT INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$8,500
-4.2%
221,400
-52.7%
0.01%
+7.7%
Q2 2023$8,874
+16.3%
467,800
-4.9%
0.01%
+30.0%
Q1 2023$7,633
+25.0%
492,112
+43.0%
0.01%
+25.0%
Q4 2022$6,108
-99.7%
344,100
-2.4%
0.01%
+166.7%
Q3 2022$1,967,000
+51.7%
352,500
+6.0%
0.00%
+50.0%
Q2 2022$1,297,000
+133.7%
332,600
+230.3%
0.00%
+100.0%
Q1 2022$555,000
+270.0%
100,700
+472.2%
0.00%
Q4 2021$150,000
-42.1%
17,600
+214.3%
0.00%
Q4 2020$259,000
-70.7%
5,600
-84.6%
0.00%
-100.0%
Q2 2020$884,00036,3000.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,717,182$139,213,0003.92%
Ghost Tree Capital, LLC 525,000$12,784,0003.37%
Logos Global Management LP 625,000$15,219,0003.04%
ACUTA CAPITAL PARTNERS, LLC 350,000$8,523,0002.46%
BVF INC/IL 1,088,479$26,504,0001.63%
Vivo Capital, LLC 800,000$19,480,0001.40%
Camber Capital Management LP 800,000$19,480,0001.12%
Sio Capital Management, LLC 152,450$3,712,0001.08%
Prosight Management, LP 95,500$2,325,0001.00%
Parkman Healthcare Partners LLC 125,125$3,047,0000.86%
View complete list of IMMUNOVANT INC shareholders